LITS

#4418
Lite Strategy, Inc. - Common Stock
0.9 8 USD
-0.02%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
0.98
0.98
Intervallo Annuale
0.69
3.23
Variazione giornaliera
-2.00%
Variazione Mensile
+3.16%
Variazione di 6 mesi
-9.26%
Variazione Annuale
-67.11%
Chiusura Precedente
1.0 0
Open
0.9 8
Minimo
0.9 8
Massimo
0.9 8
Volume
2
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi Documents

2026

Current report, Q3 FY2026
Lite Strategy, Inc. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
Lite Strategy, Inc. current report, Q3 FY2026
8-K
Current report, Q2 FY2026
Lite Strategy, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q3 FY2026
Lite Strategy, Inc. quarterly report, Q3 FY2026
10-Q
Current report, Q1 FY2026
Lite Strategy, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Lite Strategy, Inc. current report, Q1 FY2026
8-K

2025

Quarterly report, Q2 FY2025
Lite Strategy, Inc. quarterly report, Q2 FY2025
10-Q
Current report, Q4 FY2025
Lite Strategy, Inc. current report, Q4 FY2025
8-K
Current report, Q4 FY2025
Lite Strategy, Inc. current report, Q4 FY2025
8-K
Current report, Q4 FY2025
Lite Strategy, Inc. current report, Q4 FY2025
8-K

Lite Strategy, Inc. current report, 01 December 2016

Full document

Business Context and Reporting Period

This Form 8-K Current Report was filed by MEI Pharma, Inc. (not Lite Strategy, Inc.) on December 2, 2016, regarding events occurring on December 1, 2016. The report details the outcomes of the Company's Annual Meeting of Stockholders for the fiscal year ending June 30, 2017.

Key Financial Metrics

This filing is a current report regarding corporate governance and equity plan amendments. It does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The filing text does not provide a clear value for these items.

Material Changes and Corporate Actions

  • Equity Plan Amendment: Stockholders approved the Amended and Restated 2008 Stock Omnibus Equity Compensation Plan. The number of shares available for awards was increased from 6,686,000 to 10,186,000 shares.
  • Executive Departure: Thomas M. Zech, Chief Financial Officer and Secretary, announced his intention to retire no later than June 30, 2017. A search for a replacement has been initiated.
  • Director Elections: Three directors (Thomas C. Reynolds, William D. Rueckert, and Christine A. White) were elected to three-year terms expiring in 2020.
  • Auditor Ratification: BDO USA, LLP was ratified as the independent registered public accounting firm for the fiscal year ending June 30, 2017.

Guidance, Outlook, and Risks

The filing contains no forward-looking guidance, financial outlook, or specific risk factors beyond the standard disclosure of the CFO's impending retirement. The primary contingency noted is the transition of the Chief Financial Officer role by mid-2017.

Investor Verification Checklist

  • Verify the impact of the increased equity pool (10,186,000 shares) on potential future dilution.
  • Monitor the timeline and progress of the search for a replacement Chief Financial Officer following Thomas M. Zech's retirement.
  • Review the full text of the Amended and Restated 2008 Stock Omnibus Equity Compensation Plan (Exhibit 10.1) for specific terms and conditions.
  • Confirm the voting percentages for the advisory vote on executive compensation (Proposal 4), which passed with approximately 89.7% "For" votes.